Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Crow

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
The Journal of Heredity|December 23, 2016
Combining Genotype, Phenotype, and Environment to Infer Potential Candidate GenesBenoit Talbot, Ting-Wen Chen, Shawna Zimmerman, et al.
Leukemia & Lymphoma|December 1, 1996
Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomasA H Sarris, D Daliani, R Ulmer, et al.
Motivation Science|September 2, 2025
Transtheoretical Model Technology-based Interventions to Improve Health Behaviors in VeteransErica R Checko, Jeffrey Knight, Thomas M Crow, et al.
Journal of General Internal Medicine|August 12, 2018
Screening Positive for Cognitive Impairment: Impact on Healthcare Utilization and Provider Action in Primary and Specialty Care PracticesMichael Rosenbloom, Terry R Barclay, Soo Borson, et al.
Nuclear Medicine and Biology|March 4, 2008
Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion proteinPaul J Yazaki, Thewodros Kassa, Chia-wei Cheung, et al.
Journal of Consulting and Clinical Psychology|April 2, 2026
Comparing dropout from cognitive processing therapy versus prolonged exposure: Results from a randomized clinical trialKelly L Harper, Thomas M Crow, Johanna Thompson-Hollands, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomasA H Sarris, D Daliani, R Ulmer, et al.
Brain Research|June 15, 2014
Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinson׳s diseaseJ M Fine, A C Forsberg, D B Renner, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Fragment-Based Screen of SARS-CoV-2 Papain-like Protease (PL<sup>pro</sup>)Ashley J Taylor, Kangsa Amporndanai, Tyson A Rietz, et al.
Journal of the Neurological Sciences|September 6, 2017
Intranasal deferoxamine affects memory loss, oxidation, and the insulin pathway in the streptozotocin rat model of Alzheimer's diseaseJ M Fine, A C Forsberg, B M Stroebel, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
The Journal of Heredity|December 23, 2016
Combining Genotype, Phenotype, and Environment to Infer Potential Candidate GenesBenoit Talbot, Ting-Wen Chen, Shawna Zimmerman, et al.
Leukemia & Lymphoma|December 1, 1996
Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomasA H Sarris, D Daliani, R Ulmer, et al.
Motivation Science|September 2, 2025
Transtheoretical Model Technology-based Interventions to Improve Health Behaviors in VeteransErica R Checko, Jeffrey Knight, Thomas M Crow, et al.
Journal of General Internal Medicine|August 12, 2018
Screening Positive for Cognitive Impairment: Impact on Healthcare Utilization and Provider Action in Primary and Specialty Care PracticesMichael Rosenbloom, Terry R Barclay, Soo Borson, et al.
Nuclear Medicine and Biology|March 4, 2008
Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion proteinPaul J Yazaki, Thewodros Kassa, Chia-wei Cheung, et al.
Journal of Consulting and Clinical Psychology|April 2, 2026
Comparing dropout from cognitive processing therapy versus prolonged exposure: Results from a randomized clinical trialKelly L Harper, Thomas M Crow, Johanna Thompson-Hollands, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomasA H Sarris, D Daliani, R Ulmer, et al.
Brain Research|June 15, 2014
Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinson׳s diseaseJ M Fine, A C Forsberg, D B Renner, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Fragment-Based Screen of SARS-CoV-2 Papain-like Protease (PL<sup>pro</sup>)Ashley J Taylor, Kangsa Amporndanai, Tyson A Rietz, et al.
Journal of the Neurological Sciences|September 6, 2017
Intranasal deferoxamine affects memory loss, oxidation, and the insulin pathway in the streptozotocin rat model of Alzheimer's diseaseJ M Fine, A C Forsberg, B M Stroebel, et al.
Pageof 11